oa Journal of Endocrinology, Metabolism and Diabetes in South Africa - CEPHEUS recruitment target met
AstraZeneca's survey on undertreatment of hypercholesterolaemia in SA ahead of schedule : press release
AstraZeneca's national survey to quantify the degree of undertreatment of hypercholesterolaemia in this country is ahead of schedule, according to the AstraZeneca clinical team driving the study. Known as CEPHEUS (Centralised pan-South African Survey on the treatment of hypercholesterolemia), the study recruited its first patient in mid-November 2009 and just five months later, on 23 April 2010, the final patient was enrolled. A week ahead of the projected timelines, the study has completed the recruitment phase of what is expected to be a landmark survey of 3 000 patients.
Article metrics loading...